心臟去颤器全球市场规模、份额、成长分析、按产品、最终用户 - 产业预测，2024-2031 年

Global Defibrillator Market Size, Share, Growth Analysis, By Product(Implantable Cardioverter Defibrillators (ICD), and External Defibrillators (ED)), By End-User(Hospital, Pre-Hospital) - Industry Forecast 2024-2031

出版日期: 2024年03月29日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球心臟去颤器市场规模为127.6亿美元，从2023年的136.8亿美元成长到2031年的136.8亿美元，预测期间（2024-2031年）复合年增长率为7.20%，预计将成长至238.6亿美元。

市场的成长受到几个关键因素的推动，包括产品技术的进步、心臟麻痹案例的增加、社会意识的提高以及政府和医疗机构的支持措施。这项进展的一个例子是澳洲 Rapid Response Revival Research Ltd. 的突破性 CellAED 于 2021 年获得了 CE 认证，CellAED 是世界上首款专为家庭使用而设计的个人AED。儘管预防和治疗方面取得了进展，但心臟麻痹仍然是心血管死亡的一个重要原因，这促使植入式心臟整流去颤器(ICD) 和体外心臟去颤器，需求不断增加。例如，Ami Italia 提供 Saver One、Geo Saver 和 Smarty Saver 系列等心臟去颤器，多功能 Smarty 系列可用于各种情况，包括急救车辆、医疗设施和公共场所。，适用于医务人员和非医务人员。同时，微创在中国心律管理市场占据主导地位，凭藉多元化的产品系列和强大的产品线，2022年上半年收益大幅成长95%。此外，诸如迪拜救护车服务管理局 (DCAS) 向全市各地分发 80 台 AED 等倡议，以及通过 DCAS 的 Help Me 应用程序建立熟练急救人员网络等倡议也正在进行中。像“这个小镇现在拯救”这样的节目。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

Medtronic plc
Philips Healthcare
Abbott Laboratories
Boston Scientific Corporation
ZOLL Medical Corporation
Physio-Control, Inc.（a Stryker Company）
Cardiac Science Corporation
Nihon Kohden Corporation
Koninklijke Philips NV.
SCHILLER AG
CU Medical Systems, Inc.
Progetti Srl
Mindray Medical International Limited
Defibtech, LLC
LivaNova PLC
Cardionet, LLC（a BioTelemetry Company）
Biotronik SE & Co. KG
Welch Allyn（a Hill Rom Company）
Cardiac Science Corporation
Physio-Control, Inc.（a Stryker Company）

简介目录

Product Code: SQMIG35A2240

Global Defibrillator Market size was valued at USD 12.76 Billion in 2022 and is poised to grow from USD 13.68 Billion in 2023 to USD 23.86 Billion by 2031, at a CAGR of 7.20% during the forecast period (2024-2031).

The growth of the market is being propelled by several key factors, including advancements in product technology, an uptick in sudden cardiac arrest cases, heightened public awareness, and supportive initiatives from governmental and healthcare bodies. An example of this progress is evident in Rapid Response Revival Research Ltd., an Australian company, obtaining CE certification in 2021 for their groundbreaking CellAED, the world's first personal AED designed for home use, which facilitated the company's expansion plans. Despite strides in prevention and treatment, sudden cardiac arrest remains a significant contributor to cardiovascular mortality, fostering innovation and driving demand for implantable cardioverter defibrillators (ICDs) and external defibrillators. Ami Italia, for instance, offers a range of defibrillators like the Saver One, Geo Saver, and Smarty Saver lines, with the versatile Smarty Series finding application in various settings such as emergency vehicles, medical facilities, and public spaces, catering to both medical and non-medical personnel. Meanwhile, Microport dominates China's cardiac rhythm management market, recording a substantial revenue surge of 95% in the first half of 2022, owing to its diverse product portfolio and robust pipeline. Additionally, increasing awareness of cardiovascular diseases in emerging markets is driving market growth, alongside initiatives like the Dubai Corporation for Ambulance Services (DCAS) distributing 80 AEDs to diverse locations across the city, complemented by volunteer training through programs like This Town Saves Now, aimed at establishing a network of skilled responders via DCAS' Help Me app.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Defibrillator Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Defibrillator Market Segmental Analysis

The global defibrillator market is segmented based on product, end user, and region. Based on product, the market is segmented into implantable cardioverter defibrillators (ICD), and external defibrillators (ED). With respect to categorization by end-use, the market is segmented into hospital, pre-hospital, public access market, alternate care market, and home healthcare. Regionwise, the global defibrillator market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Defibrillator Market

The surge in specific target diseases is exerting a profound influence on global healthcare. Cardiovascular ailments, encompassing coronary artery disease and cardiac arrest, impact a considerable segment of the world's populace, resulting in a rising mortality rate. In 2021, data from the Centers for Disease Control and Prevention (CDC) linked approximately 695,000 deaths in the United States to cardiovascular diseases. Particularly, coronary artery disease heightens the risk of sudden cardiac death due to arrhythmias. A 2022 report from the Coronary Artery Disease Foundation indicates an annual occurrence of roughly 356,000 out-of-hospital cardiac arrests (OHCA) in the United States. Lifestyle-related factors such as obesity, hypertension, dyslipidemia, and diabetes significantly contribute to the heightened risk of various cardiovascular conditions. Moreover, the global aging populace serves as a pivotal factor driving the escalating prevalence of cardiovascular diseases. Aging correlates with an increased susceptibility to developing ventricular arrhythmias, primarily attributable to the progressive degradation and heightened complexity in the structure and functionality of the heart, thereby fostering a burgeoning prevalence of arrhythmias among the elderly.

Restraints in the Global Defibrillator Market

The adoption of defibrillators, particularly advanced ones such as ICDs and implantable devices, may be hindered by their relatively high costs, which can constrain market expansion, especially in areas with constrained healthcare budgets or insufficient insurance coverage.

Market Trends of the Global Defibrillator Market

The defibrillator market is experiencing swift technological progressions focused on improving device functionality, user-friendliness, and patient results. Prominent advancements involve the incorporation of artificial intelligence (AI) algorithms to enhance the precision of cardiac rhythm detection, wireless connectivity for distant monitoring and data transfer, and upgraded user interfaces for simplified operation.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Defibrillator Market by Product

Market Overview
Implantable Cardioverter Defibrillators (ICD)
and External Defibrillators (ED)

Global Defibrillator Market by End-User

Market Overview
Hospital
Pre-Hospital
Public Access Market
Alternate Care Market
and Home Healthcare

Global Defibrillator Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZOLL Medical Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Physio-Control, Inc. (a Stryker Company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardiac Science Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nihon Kohden Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips NV.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SCHILLER AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CU Medical Systems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Progetti S.r.l.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mindray Medical International Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Defibtech, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardionet, LLC (a BioTelemetry Company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Welch Allyn (a Hill Rom Company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardiac Science Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Physio-Control, Inc. (a Stryker Company)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments